These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8266138)

  • 1. An unusual cause of giddiness. Fig. 1: Complete heart block with prolonged QT interval. Fig. 2: Torsades de pointes.
    Ng KS; Choo MH
    Singapore Med J; 1993 Feb; 34(1):81-2, 92. PubMed ID: 8266138
    [No Abstract]   [Full Text] [Related]  

  • 2. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes.
    Ghosh S; Apte P; Maroz N; Broor A; Zeineh N; Khan IA
    Int J Cardiol; 2009 Aug; 136(2):225-7. PubMed ID: 18617280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-loop, clockwise QT-RR hysteresis immediately before the onset of torsades de pointes in type 2 long QT syndrome.
    Nakaji G; Fujiwara M; Fukata M; Yasuda S; Odashiro K; Maruyama T; Akashi K
    J Electrocardiol; 2010; 43(3):261-3. PubMed ID: 20079908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired long QT syndrome: long-term electrocardiographic (Holter) recording of torsades de pointes ending in asystole: II.
    Raviña T; Gutierrez J; Raviña P
    Int J Cardiol; 2007 Mar; 116(2):272-5. PubMed ID: 16859777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome.
    Kawabata M; Hirao K; Takeshi S; Sakurai K; Inagaki H; Hachiya H; Isobe M
    J Electrocardiol; 2008; 41(2):117-22. PubMed ID: 18328336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Takotsubo cardiomyopathy associated with torsades de pointes and long QT interval: a case report].
    Okada T; Miyata S; Hashimoto K; Maie K; Mochizuki S
    J Cardiol; 2007 Jul; 50(1):83-8. PubMed ID: 17685032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsades de pointes complicating complete heart block with QT interval prolongation.
    Stankovic I; Putnikovic B; Neskovic AN
    Acta Cardiol; 2016; 71(5):627. PubMed ID: 27695027
    [No Abstract]   [Full Text] [Related]  

  • 10. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-QT syndrome and torsades de pointes in a patient with Takotsubo cardiomyopathy: an unusual case.
    Mahida S; Dalageorgou C; Behr ER
    Europace; 2009 Mar; 11(3):376-8. PubMed ID: 19095686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acquired long QT syndrome with torsade de pointes in a patient with primary hypothyroidism].
    Kukla P; Szczuka K; Słowiak-Lewińska T; Bromblik A; Hajduk B; Kluczewski M; Lenard B; Przewor M
    Kardiol Pol; 2003 Mar; 58(3):224-6. PubMed ID: 14513098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for constructing and estimating the RR-memory of the QT-interval and its inclusion in a multivariate biomarker for torsades de pointes risk.
    Trost DC
    J Biopharm Stat; 2008; 18(4):773-96. PubMed ID: 18607807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsade de pointes: the clinical considerations.
    Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced prolongation of the QT interval.
    Curigliano G; Cipolla C; de Braud F
    N Engl J Med; 2004 Jun; 350(25):2618-21; author reply 2618-21. PubMed ID: 15208787
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adenosine for diagnosing long QT syndrome].
    Michowitz Y; Viskin S
    Harefuah; 2009 Aug; 148(8):563. PubMed ID: 19899265
    [No Abstract]   [Full Text] [Related]  

  • 18. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
    J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipe for Torsades de Pointes.
    Scheibly K; Tsiperfal A
    Prog Cardiovasc Nurs; 2009 Mar; 24(1):39-41. PubMed ID: 19261144
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current principles of the treatment of prolonged QT interval syndrome].
    Popov SV; Gimrikh EO; Pekarskiĭ VV
    Klin Med (Mosk); 1990 Nov; 68(11):8-12. PubMed ID: 1980933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.